Jefferies Upgrades 10x Genomics to Buy, Maintains Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Tycho Peterson has upgraded 10x Genomics (NASDAQ:TXG) from Hold to Buy, while maintaining the price target at $24.
July 22, 2024 | 10:27 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Tycho Peterson has upgraded 10x Genomics (NASDAQ:TXG) from Hold to Buy, while maintaining the price target at $24.
The upgrade from Hold to Buy by a reputable analyst at Jefferies is likely to positively impact the stock price of 10x Genomics in the short term. Maintaining the price target at $24 suggests confidence in the stock's current valuation and potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100